Connection

Michael von Bergwelt-Baildon to Withholding Treatment

Back to Details
This is a "connection" page, showing publications Michael von Bergwelt-Baildon has written about Withholding Treatment.
Michael von Bergwelt-Baildon
Connection Strength
0.036
Withholding Treatment
  1. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med. 2021 08; 9(8):863-872.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.